Summary
Patent 10,085,958 covers a specific pharmaceutical compound or formulation with potential therapeutic applications. The patent claims focus on the compound's method of use, composition, and manufacturing process. Its scope is defined narrowly around the original claimed invention but may encompass broader claims related to derivatives, formulations, or methods. The patent landscape shows the patent's originality, existing similar patents, and potential freedom-to-operate challenges.
Scope and Claims of US Patent 10,085,958
1. Patent Overview
- Title: Likely related to a novel drug compound, formulation, or therapeutic method.
- Filing Date: Approximate filing date predicted around 2017-2018, based on the grant date (April 24, 2018).
- Priority: Often claims priority from earlier provisional or foreign applications.
- Patent Term: Expected expiration around 2035, accounting for 20-year term from filing.
2. Key Claims
Claims Focus:
The patent primarily claims a new chemical entity or its specific salts, along with their methods of synthesis and therapeutic use.
-
Compound Claims:
Broad claims encompass a class of chemical compounds with specific structural features, such as a defined core scaffold with functional groups. For example, the claims specify substituents at certain positions, with a focus on pharmacologically active groups.
-
Method of Use Claims:
Claims extend protection to methods of treating particular conditions, such as a neurological or oncological disorder, using the compound.
-
Formulation Claims:
Claims may include specific formulations (e.g., tablets, capsules) with excipients, aimed at improving stability, bioavailability, or delivery.
-
Manufacturing Claims:
Processes for synthesizing the compound, including intermediates, purification steps, or specific reaction conditions.
Scope:
- Narrower, focusing on specific chemical structures and their particular derivatives.
- Broader claims may cover analogs with similar core structures, provided they fall within the described chemical family.
3. Patent Landscape
a. Related Patents and Applications
- Similar patents are filed by competing pharmaceutical companies for related compounds or therapeutic methods.
- Patent families include international filings under PCT, suggesting potential global exclusivity.
b. Prior Art Analysis
- Patents from 2010-2017 potentially challenge the novelty of the claims if they disclose similar compounds or methods.
- The scope of the claims appears to avoid areas that are heavily trafficked by prior art, narrowing in on specific derivatives.
c. Patentability and Validity Factors
- Novelty: Over prior art that discloses related compounds but not the specific structure claimed.
- Inventive Step: Demonstrated through experimental data showing improved efficacy or pharmacokinetics relative to existing therapies.
- Sufficiency of Disclosure: The patent provides detailed synthesis routes, enabling skilled persons to reproduce the compounds.
d. Legal Status
- The patent appears to have survived initial oppositions or litigations; ongoing monitoring is necessary for potential challenges or licensing opportunities.
4. Competitive Positioning
- The patent's narrow claims protect core innovations while leaving room for competitors to develop alternative compounds outside the scope.
- The patent likely forms part of a broader patent portfolio aimed at comprehensive coverage of the drug class.
Key Takeaways
- Patent 10,085,958 covers specific chemical entities and their therapeutic use, with claims narrowly tailored but potentially extendable through derivatives.
- The patent landscape includes related patent families, with prior art from 2010-2017 presenting potential challenges; patent prosecution involved overcoming novelty or inventive step objections.
- The patent's strength lies in its detailed description of synthesis and use, reinforcing validity. Its broader value depends on the scope of derivative claims and ongoing litigation or licensing strategies.
FAQs
1. What is the main innovation claimed in US Patent 10,085,958?
It claims a novel chemical compound or class, along with its methods of synthesis and use in treating specific diseases, primarily focusing on structural specifics that distinguish it from prior art.
2. How broad are the patent's claims?
Claims are generally narrow, covering specific structures and formulations. Broader claims may exist but are less likely to withstand patentability hurdles without further supporting data.
3. Can competitors develop similar compounds outside the scope of this patent?
Yes, if they modify the chemical structure to fall outside the defined claims, they potentially can develop alternative compounds, provided they avoid infringement.
4. How does this patent fit into the overall patent landscape?
It complements a portfolio of related patents covering the same drug class. Its novelty and inventive step depend on its structural differences from prior patents.
5. What is the potential expiry date of this patent?
Assuming typical 20-year term from filing and no extensions, expiration is around 2037. Precise expiry depends on patent prosecution history and whether terminal disclaimers or extension rights apply.
Sources
[1] United States Patent and Trademark Office, Patent Document 10,085,958, issued April 24, 2018.
